FDA Demands "Boxed Warning" to CAR T-Cell Therapy Labels
Zacks Investment Research
The FDA directs companies like NVS, BMY, GILD and others to add "boxed warning" to the labels of their CAR T-cell immunotherapies after it identified adverse events.
Continue Reading